UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis

Frontiers in endocrinology (Lausanne), 2017-08, Vol.8, p.187-187

2017

Link zum Volltext

Verfügbarkeit prüfen

Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer

International journal of molecular sciences, 2022-05, Vol.23 (9), p.5050

2022

Link zum Volltext

Verfügbarkeit prüfen

Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death

Frontiers in oncology, 2020-03, Vol.10, p.409-409

2020

Link zum Volltext

Verfügbarkeit prüfen

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Frontiers in endocrinology (Lausanne), 2019-01, Vol.9, p.781-781

2019

Link zum Volltext

Verfügbarkeit prüfen

The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.292

2021

Link zum Volltext

Verfügbarkeit prüfen

Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells

International journal of molecular sciences, 2023-09, Vol.24 (18), p.13705

2023

Link zum Volltext

Verfügbarkeit prüfen

17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib

Oncology reports, 2017-02, Vol.37 (2), p.1212-1218

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.437

2021

Link zum Volltext

Verfügbarkeit prüfen

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.199-205

2012

Link zum Volltext

Verfügbarkeit prüfen

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling

Scientific reports, 2020-10, Vol.10 (1), p.17889, Article 17889

2020

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells

International journal of oncology, 2015-02, Vol.46 (2), p.878-884

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer

Cancers, 2023-05, Vol.15 (10), p.2845

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion

Frontiers in oncology, 2019-10, Vol.9, p.1074-1074

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

Cells (Basel, Switzerland), 2021-09, Vol.10 (9), p.2398

2021

Link zum Volltext

Verfügbarkeit prüfen

HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.714

2021

Link zum Volltext

Verfügbarkeit prüfen

GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (16), p.6473-6481

2009

Link zum Volltext

Verfügbarkeit prüfen

Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH

International journal of oncology, 2016-06, Vol.48 (6), p.2713-2721

2016

Link zum Volltext

Verfügbarkeit prüfen

Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors

Oncology reports, 2017-04, Vol.37 (4), p.2418-2424

2017

Link zum Volltext

Verfügbarkeit prüfen

Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

Breast cancer research and treatment, 2014-11, Vol.148 (2), p.269-277

2014

Link zum Volltext

Verfügbarkeit prüfen

Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo

Breast cancer research and treatment, 2011-12, Vol.130 (3), p.783-790

2011

Link zum Volltext

Verfügbarkeit prüfen

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.337-346

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10

Breast cancer research and treatment, 2015-07, Vol.152 (1), p.41-50

2015

Link zum Volltext

Verfügbarkeit prüfen

Die HPO(Hypothalamus-Hypophyse-Ovar)-Achse – „revisited

Gynäkologe (Berlin), 2020-08, Vol.53 (8), p.494-501

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer

Reproductive biology and endocrinology, 2003-10, Vol.1 (1), p.65-65

2003

Link zum Volltext

Verfügbarkeit prüfen

Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells: Evidence for a dose–window effect

Gynecologic oncology, 2010-12, Vol.119 (3), p.571-578

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(95)

Sprache

Englisch
(93)
Japanisch
(13)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(74)
Humans
(63)
Female
(59)
Oncology
(40)
Breast Cancer
(33)
Biological And Medical Sciences
(31)
Tumors
(31)
Medical Sciences
(29)
Cell Line, Tumor
(28)
Gonadotropin-Releasing Hormone - Analogs & Derivatives
(25)
Gonadotropin-Releasing Hormone - Pharmacology
(24)
Breast Neoplasms - Metabolism
(18)
Gynecology. Andrology. Obstetrics
(18)
Breast Neoplasms - Pathology
(16)
Endocrinology & Metabolism
(15)
Metastasis
(15)
Receptors, Lhrh - Metabolism
(15)
Triptorelin Pamoate - Pharmacology
(15)
Apoptosis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis

Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer

Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer

Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells

17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling

Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review

GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax

Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH

Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors

Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo

Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10

Die HPO(Hypothalamus-Hypophyse-Ovar)-Achse – „revisited

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer

Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells: Evidence for a dose–window effect

Suchergebnisse filtern